Proximod as a potential therapy for rheumatoid arthritis

Chao Liang

doi:10.1016/S2665-9913(24)00237-6

Proximod as a potential therapy for rheumatoid arthritis

Chao Liang^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	e814-e815
Number of pages	2
Journal	The Lancet Rheumatology
Volume	6
Issue number	12
DOIs	https://doi.org/10.1016/S2665-9913(24)00237-6
Publication status	Published - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2665-9913(24)00237-6

Cite this

@article{927882c289044b35b95e03dc4842941a,

title = "Proximod as a potential therapy for rheumatoid arthritis",

author = "Chao Liang",

note = "Publisher copyright: {\textcopyright} 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.",

year = "2024",

month = dec,

doi = "10.1016/S2665-9913(24)00237-6",

language = "English",

volume = "6",

pages = "e814--e815",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - Proximod as a potential therapy for rheumatoid arthritis

AU - Liang, Chao

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85208469120

U2 - 10.1016/S2665-9913(24)00237-6

DO - 10.1016/S2665-9913(24)00237-6

M3 - Editorial

AN - SCOPUS:85208469120

SN - 2665-9913

VL - 6

SP - e814-e815

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 12

ER -

Proximod as a potential therapy for rheumatoid arthritis

UN SDGs

Access to Document

Other files and links

Cite this